GENE ONLINE|News &
Opinion
Blog

Clinical Trial
Trials & Approvals
Citius Pharma Makes Calculated Market Moves with Phase 3 Results Looming for Potential Blockbuster Product
2021-02-21
Trials & Approvals Tapinarof
Dermavant Sciences’ Psoriasis Drug Promises in Phase 3 Trials
2021-02-20
Trials & Approvals Tyrosine Kinase 2
Bristol Myers Squibb Registers Another Trial Win for its Psoriasis Med
2021-02-03
Trials & Approvals Immutep
Immutep Announces Discontinuation of Phase 2 Ulcerative Colitis Study by GSK
2021-01-30
Trials & Approvals Alzheimer's Disease
Biohaven’s Troriluzole Joins Long List of Failed Alzheimer’s Drugs
2021-01-21
R&D Heart Failure
Merck and Bayer Enter the Congested Market of Heart Failure with Verquvo
2021-01-21
Trials & Approvals
Lilly’s Donanemab Aces Phase 2 Trial, Slows Clinical Decline in Alzheimer’s Patients
2021-01-15
COVID-19 Vaccine
Philippines Signs Second Vaccine Deal to Procure 30 Million Doses of Novavax’s Covovax
2021-01-12
Trials & Approvals Gene Therapy
Sarepta’s Stocks Drop 50% Following Middling Trial Data for Gene Therapy
2021-01-11
Trials & Approvals Sickle Cell Disease
Imara’s Sickle Cell Disease Therapy Impresses in Phase 2 Trial
2021-01-09
Trials & Approvals RNAi
Alnylam Nears Fourth Approval with Successful Trial Data for RNAi Drug
2021-01-08
Trials & Approvals PARP Inhibitor
Lynparza Bags Multiple Approvals in Japan
2021-01-05
Trials & Approvals Clinical Trial
Amgen and AstraZeneca’s Asthma Drug Flunks Phase 3 Trial
2020-12-26
Trials & Approvals Parkinson’s Disease
Voyager Encounters Regulatory Bump in Parkinson’s Trial
2020-12-25
Trials & Approvals
uniQure’s Hemophilia B Gene Therapy Put on Clinical Hold by the FDA
2020-12-22
1 2 3 4 5 6 … 14
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top